Psyence Group Inc. (CSE:PSYG)

Canada flag Canada · Delayed Price · Currency is CAD
0.0150
0.00 (0.00%)
Mar 24, 2025, 11:11 AM EST
-57.14%
Market Cap 2.11M
Revenue (ttm) n/a
Net Income (ttm) -65.83M
Shares Out 140.45M
EPS (ttm) -0.47
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 6,200
Average Volume 21,779
Open 0.0150
Previous Close 0.0150
Day's Range 0.0150 - 0.0150
52-Week Range 0.0100 - 0.0500
Beta 1.74
RSI 57.77
Earnings Date Jul 30, 2025

About Psyence Group

Psyence Group Inc., a life science biotechnology company, engages in the cultivation and production of commercial psilocybin mushroom. It operates in two segments: Clinical Trial Activities and Non-Clinical Trial Activities. The company natural psilocybin is used for the treatment of a range of mental health disorders and other medical conditions. It also focuses on the development, distribution, and sale of over-the-counter non psilocybin containing functional mushroom nutraceutical products under the GOODMIND brand. The company was founded in... [Read more]

Sector Healthcare
Founded 2019
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol PSYG
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.